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Abstract 15 
 16 
In the last 20 years, there has been an increasing interest in using various seaweed extracts as 17 
prophylactic and/or therapeutic agents in aquaculture. Up until now, most studies on the direct 18 
antimicrobial effect of seaweeds have taken place in various parts of Asia, particularly in 19 
India. All groups of seaweeds exhibit significant antimicrobial properties against many 20 
infectious agents of fish and shrimp, but the genera that appear to exhibit a broader range of 21 
antibacterial properties are Asparagopsis spp. (red seaweed) and Sargassum spp. (brown 22 
seaweed). The activity, can be affected by many factors and the method of extraction is one of 23 
the most important ones, as the extracts that are produced using organic solvents appear more 24 
efficient. In fish, almost all published information on bacterial pathogens comes from in vitro 25 
screenings, where extracts of different seaweed species were tested against many bacterial 26 
species. On the other hand, in shrimp, the studies have been focusing on the antimicrobial 27 
effects of seaweed extracts mainly against many Vibrio species. Regarding the viral 28 
pathogens, in fish there is only one published study on fish viruses (IHNV and IPNV), while 29 
in shrimp there are many studies on WSSV. There are only two published studies on fish 30 
parasites (I. hoferi and Neobendenia spp.) and no studies on pathogenic fish and shrimp fungi. 31 
Interestingly, there are no published studies on salmons and carps, the main fish species that 32 
are extensively farmed. When the antimicrobial properties were studied in vivo, the seaweed 33 
extracts were either incorporated directly in the feeds (dry or live), or added directly into the 34 
water in which the fish and shrimp were reared. In the last case, the water-soluble 35 
antimicrobial seaweed substances affected the communication between the bacterial 36 
pathogens, rather than their growth. The development of parasites was also affected. In 37 
addition, one study indicated that short-term immersion of shrimp in seaweed extracts 38 
appeared to have a therapeutic effect against Vibrio parahaemolyticus. On the other hand, 39 
incorporation of the extracts into the feeds appeared to be an effective delivery method for the 40 
prevention and treatment of different infectious diseases. Up until now there are no complete 41 
studies on the pharmacodynamics and pharmacokinetics of seaweed extracts in fish or shrimp. 42 
However, the findings indicate that they can reduce the bacterial load within the tissues. 43 
Another issue that has not been examined yet is the applicability of using these extracts on a 44 
commercial scale. Currently, the increased extraction cost inhibits the extensive use of these 45 
extracts. Other methodologies, such the production of synthetic analogues with similar 46 
properties, may decrease the production cost.  Based on the published studies, seaweed 47 
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extracts exhibit promising antimicrobial properties, but further research is needed before the 48 
complete potential of seaweed extracts is assessed. 49 
 50 
Keywords Seaweed, antimicrobial, fish, shrimp, aquaculture  51 
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Introduction 52 
 53 
With an average annual growth rate of 8.9 % since 1970, aquaculture is considered to be the 54 
fastest growing food-producing sector in the world and accounts for about 36 % of the global 55 
fish supply and almost 60% of the global shrimp supply (FAO, 2014). In terms of quantity, 56 
farming of cyprinids dominates the aquaculture production, with 25.4 million T, while the 57 
production of salmonids and crustaceans (shrimp and prawns) contributes with 3.2 and 4.3 58 
million T respectively (FAO, 2014). Diseases, either infectious or non-infectious, are 59 
important limiting factors that affect the production volume and consequently the production 60 
cost. In 2006, for instance, for a global production of 1.6 million T of salmon, the cost for sea 61 
lice treatments was estimated at 305 million € (Costello, 2009). It has been estimated that in 62 
Norway, the top salmonid producer in the world, the cost of sea lice control is about 0.19 € 63 
kg-1 of salmon (Costello, 2009). Furthermore, it was estimated that in 2010, over 77 million 64 
USD were spent in Norway on fish diseases management, including the implementation of 65 
legislation and support to surveillance and control programmes (The Fish Site, 2010). 66 
The development of many vaccines, mainly against fish pathogens and the use of various 67 
antimicrobial agents have reduced the impact of many diseases. However, there is currently 68 
an increasing demand for more environment-friendly disease control schemes and many 69 
researchers have examined alternative approaches. Among these approaches, the use of 70 
various natural products that derive from different living organisms, such as plants (e.g. 71 
essential oils), animals (e.g. chitozan) and seaweeds has received a lot of attention (Romero et 72 
al., 2012).  73 
Seaweeds, also known as macroalgae, are photosynthetic multicellular aquatic organisms 74 
that can be found in almost every aquatic environment, in all geographical areas. Humans had 75 
realized their important value as early as 14,000 years ago (Dillehay, et al., 2008). The first 76 
reports of seaweeds growing on ropes used for fish farming came from Japan, about 400 years 77 
ago (Buchholz et al., 2012). A more systematic culture started in the 1950’s, in order to meet 78 
the increasing demand for seaweeds as food and mostly as sources of polymers. In 2012, over 79 
21 million tons of seaweeds were produced, over 96 % of which were cultured in Asia (FAO, 80 
2014). 81 
Many studies, on different seaweed species have confirmed their nutritional value. In 82 
particular, seaweeds are low in calories, have high content of dietary fibers, are a good source 83 
of polyunsaturated fatty acids DHA and EPA and may contain proteins up to 44% dry matter 84 
with an amino acid profile of interest (Holdt and Kraan, 2011). The red and the green 85 
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seaweeds are generally rich in carbohydrates, whereas the brown seaweeds are generally 86 
richer in soluble fiber and iodine (Gupta and Abu-Ghannam 2011a). In some cases some 87 
essential amino acids might be limiting, as for example tryptophan, while the concentration of 88 
other amino acids, like taurine, can be high particularly in red algae (Dawczynski et al., 89 
2007). In addition to their nutritional value, seaweeds exhibit interesting pharmacological 90 
properties, such as antioxidant, anti-inflammatory, antimicrobial and even anticancer 91 
properties (El Gamal, 2010; Gupta and Abu-Ghannam 2011a; Gupta and Abu-Ghannam 92 
2011b;  Holdt and Kraan 2011; Mohamed et al., 2012). The active compounds include 93 
polysaccharides (e.g. fucoidan), various phytochemicals (e.g. phlorotannins), carotenoids, 94 
minerals, peptides and lipids (Gupta and Abu-Ghannam 2011b; Holdt and Kraan 2011). It is 95 
worth mentioning that some of these compounds, as for example phlorotannins, are not found 96 
in terrestrial plants.  97 
The present review focuses on published studies on the direct antimicrobial properties of 98 
seaweeds and their extracts against various pathogens of farmed fish and shrimp. Many of 99 
these extracts also exhibit significant immunostimulatory (Caipang et al., 2011) and 100 
antioxidant properties (Kang et al., 2013; Wijesinghe et al., 2014), which can enhance the 101 
resistance and immune response against many infectious agents, but these will not be 102 
discussed in the present review. 103 
 104 
Control of infectious diseases in aquaculture 105 
 106 
In contrast to terrestrial farmed animals, most of the fish species that are farmed today 107 
have been recently domesticated from wild populations and thus they are still not well 108 
adapted to the conditions that exist in farms (Kibenge et al., 2012). Many of these conditions, 109 
such as crowding, regularly handling, improper water quality parameters and the use of 110 
artificial commercial feeds, can cause various degrees of stress to fish, which in turn can make 111 
them more vulnerable to all infectious diseases (Huntingford et al., 2006). As a rule, the most 112 
common infectious diseases that are observed in farmed aquatic animals are those associated 113 
with bacterial pathogens (about 50%), followed by the viral, the parasitic and finally the 114 
fungal diseases (McLoughlin, 2006). Differences, depending on the species and country, may 115 
exist. For instance, in farmed salmonids bacterial diseases are not considered a major 116 
problem, compared to the losses caused by viral agents, but in marine fish species bacterial 117 
diseases are far more important in terms of financial loss and frequency (Johansen et al., 118 
2011).The control of the infectious diseases that affect the farmed aquatic animals relies on 119 
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the use of effective prophylactic as well as therapeutic measures. Numerous studies have 120 
demonstrated that the extensive use of various chemotherapeutants used for the treatment of 121 
the parasitic, bacterial and fungal diseases in aquaculture have serious impacts on the 122 
environment and increase the health risks for both humans and animals (Burridge et al., 123 
2010). It is well established for instance, that the extensive use of various chemicals induces a 124 
strong selective pressure on the pathogens, resulting in the appearance of multi-resistant 125 
strains. Subsequently, through the horizontal exchange of genetic material that occurs 126 
between bacterial species this resistance, which is an important virulence factor for many 127 
pathogens, is transferred to other pathogens. Furthermore, the resistance to the antimicrobial 128 
agents that is developed in animal bacterial pathogens can be also transferred to human 129 
pathogens (Martinez, 2009).  130 
In aquaculture, the main routes of administration of the various chemotherapeutants are 131 
either via medicated feeds or by immersion. Both of these methods can have a direct impact 132 
on a wide range of bacterial species that live in the aquatic environment. In both cases, it is 133 
very difficult to control the leaching of the active substances to the immediate environment 134 
(Heuer et al., 2009) and thus residues of many antimicrobials are often found in the sediment 135 
under the fish and shellfish farms (Petersen et al., 2002; Romero et al., 2012). Miranda and 136 
Zemelman (2002) studied the presence of oxytetracycline-resistant bacteria in the 137 
environment of Chilean salmon farms and found that the number of oxytetracycline-resistant 138 
bacteria was significantly increased in the effluent water. The presence of these resistant 139 
bacteria was associated with previous treatments that took place in the farms. These findings 140 
are of great significance as many in vitro studies have already demonstrated the transferability 141 
of antibiotic resistance genes between fish or shrimp and human pathogens (Heuer et al., 142 
2009). Moreover, the use of the various chemotherapeutants, including the antibiotics, has 143 
negative effects on many functions of the fish immune system. Romero et al. (2012) in their 144 
review on the use of antibiotics in aquaculture noted that treatment with oxytetracycline and 145 
oxolinic acid could induce significant immunosuppression in many fish species, while a less 146 
pronounced effect was observed after a treatment with florfenicol. All these findings stress 147 
therefore the urgency to minimize the use of any chemotherapeutant in aquaculture and 148 
indeed many countries have already developed strict legislations concerning their uses. 149 
This necessity to reduce the use of chemicals is an important issue not only in aquaculture 150 
but in the whole animal farming industry. According to a report by World Human 151 
Organization (WHO, 2011) the implementation of effective biosecurity measures, the 152 
development of new vaccines, the use of prebiotics and probiotics, and good hygiene and 153 
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management practices are quite important for the control of many infectious diseases in both 154 
terrestrial and aquatic animal farming and can lead to a significant reduction in the use of 155 
antibiotics in animal farming. Furthermore, new legislations that would regulate and monitor 156 
the use of antibiotics should be implemented, while the use of antibiotics as growth promoters 157 
should be banned worldwide. Only qualified people, preferably veterinarians, should be 158 
responsible for monitoring the use of all chemicals used in animal farming. Experience from 159 
the terrestrial animal husbandry indicates that indeed strict legislations that require reduced 160 
use of antibiotics do not necessary result in increased costs to the farmers, as for example a 161 
survey in swine farms in Denmark has demonstrated (Aarestrup et al., 2010).  162 
There is however a significant variation between countries concerning the use of 163 
chemotherapeutants, which may reflect the diverse degree of awareness of each society for 164 
environmental issues. This results in heterogeneity between the legislations in effect, in 165 
aquaculture producing countries. For example, Burridge et al., (2010) reported that the 166 
amount of antibiotics used in salmon farming between 2007 and 2008 in Chile and Norway, 167 
the two main salmon producing countries, was a few hundred metric tons in Chile and less 168 
than a metric ton in Norway. Furthermore, in many countries fish and shellfish farmers use 169 
increased amounts of various antimicrobial substances, even on a daily basis, as a preventive 170 
measure (Heuer et al., 2009).   171 
As societies become more aware of the negative effects of the various treatments that are 172 
employed today in the control of the infectious diseases in aquaculture, various alternative 173 
approaches have been suggested. These include the use of probiotics to enhance the immune 174 
response of fish and shellfish, the use of bacteriophages against bacterial pathogens and the 175 
use of various natural products, such as essential oils, as antimicrobial agents (Romero et al., 176 
2012). Among them, seaweeds have also been examined as potential sources of antimicrobial 177 
substances (Gupta and Abu-Ghannam, 2011b). 178 
 179 
Seaweeds versus fish and shrimp pathogens 180 
 181 
The dietary value of seaweeds, as potential substitutes for fishmeal, or as binding agents, 182 
has been extensively studied and the findings indicate that seaweed-based diets can be used 183 
for the farming of many aquatic organisms, such as fish, shrimp, sea urchins and abalones 184 
(Bindu and Sobha, 2004; Henry, 2012). Seaweeds have relatively simple cultivation methods 185 
and can grow fast. It is also possible to control the production of some of their bioactive 186 
extracts through the manipulation of the cultivation conditions (Plaza et al., 2008). Recent 187 
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studies have focused on culture systems integrating seaweed with fish or shrimp production. 188 
In these Integrated Multitrophic Aquaculture Systems (IMTA), the seaweeds play an 189 
important role first as biofilters and secondly as a source of biomass (Barrington et al., 2009). 190 
Seaweeds receive the nutrient-rich waste water from the fish or shellfish and use it for their 191 
growth. In this way, they can reduce the negative environmental impacts of fish farming 192 
through the removal of the waste materials (mainly N and P) that are released from the 193 
animals in the farms. The produced seaweed biomass adds market value to the production 194 
system as they can later be used in food, or pharmaceutical industry (Al-Hafedh et al., 2012).  195 
The antimicrobial properties of seaweed extracts against many human and terrestrial 196 
animal pathogens are known since the end of the 19th century (Genovese et al., 2012). These 197 
antimicrobial properties can be affected by many factors, such as the habitats, the cultivation 198 
method, the growth stage of seaweeds, the season and the method used for the extraction of 199 
the bioactive components (Karthikaidevi et al., 2009; Govindasamy et al., 2011). For 200 
example, Osman et al. (2012), after screening many seaweed species against Bacillus subtilis, 201 
Staphylococcus aureus, Streptococcus spp. and Escherichia coli, found that green seaweeds 202 
and particularly Ulva fasciata, tended to exhibit higher antimicrobial activity. This was more 203 
pronounced when the green seaweeds were collected in winter. On the other hand, Salvador et 204 
al. 2007, found that red seaweeds exhibited higher antimicrobial properties against many 205 
bacterial species, particularly the seaweeds which were collected in autumn. Regarding the 206 
method of extraction, organic solvents generally tend to be more efficient for the extraction of 207 
the active substances than water (Abu-Ghannam and Rajauria, 2013) and fractioned seaweed 208 
extracts appear more effective compared to crude (Radhika et al., 2014). One important 209 
characteristic of seaweeds that may pose a health risk is that they are prone to absorb heavy 210 
metals from their surrounding environment, especially if they are located in particularly 211 
polluted areas (Bailey et al., 1999). Furthermore, they may contain substances, such as 212 
kainoids, aplysiatoxins and polycavernosides, which may be toxic to humans and animals 213 
(Smit, 2004). For example, significant ichthyotoxic effects have also been reported by De 214 
Lara-Isassi et al. (2000), who used Carassius auratus to assess the toxicity of over 70 215 
seaweed species. They concluded that Rhodophyta tended to be more toxic, while 216 
Chlorophyta appeared to be the least toxic. In some cases, the seaweed extracts can be toxic to 217 
certain fish and shellfish species, even at sub-antimicrobial concentrations (Mata et al., 2013).  218 
In farmed fish, most studies on the antimicrobial properties of seaweeds have focused on 219 
various bacterial pathogens (14 out of the 17 presented in this review), while fewer studies 220 
exist on viral and parasitic pathogens (1 and 2 respectively out of the 17 presented in this 221 
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review). On the other hand, in farmed shrimp, the studies focused mainly on various 222 
pathogenic vibrios and the White Spot Syndrome Virus. Interestingly, although there are in 223 
vitro studies in the literature that demonstrate the antifungal activities of many seaweed 224 
extracts against human pathogenic fungi, such as Aspergillus spp. and Candida albicans 225 
(Plaza et al., 2010; Omar et al., 2012), there are no similar studies on the main pathogenic fish 226 
or shrimp fungi.  227 
Despite the numerous studies on the antimicrobial effects of seaweed extracts against fish 228 
and shrimp pathogens, there is still limited information on the exact mechanism of action for 229 
most of these extracts. The reason is that although an assessment of any antimicrobial 230 
substance, as in the case of seaweed extracts, should include an initial in vitro screening 231 
followed by an in vitro study (Figure 1), most studies on the antimicrobial effects of seaweeds 232 
in fish and shrimp are either only in vitro or only in vivo. For example, 8 out of the 39 studies 233 
on seaweeds versus fish and shrimp pathogens discussed in this review included both in vitro 234 
and in vivo assays (Table 1 and 2). Furthermore, none of the eight studies on the White Spot 235 
Syndrome Virus included any preliminary in vitro study. Thus, it is not always clear if the 236 
observed protective result is either due to the direct antimicrobial effect, or due to 237 
immunostimulation, or the synergic effect.  238 
 239 
Bacterial pathogens 240 
 241 
The main identified active antibacterial compounds found in seaweeds are: fatty acids, 242 
lipophilic and phenolic compounds, lectins, acetogenins, terpenes, alkaloids, polyphenolics, 243 
isoprenoid metabolites and hydrogen peroxide (Mohamed et al., 2012). In general, these 244 
substances can a) attack the bacterial cell walls and the cell membranes, which results in an 245 
extensive release of intracellular substances or/and disruption of the uptake and transportation 246 
of substances, as for example various phlorotannins (Hierholtzer et al., 2012) b) reduce the 247 
protein and nucleic acid synthesis in the bacterial cells (Cai et al., 2014) and c) inhibit 248 
respiration (Cai et al., 2014). Phlorotannins, as many other terrestrial tannins do, may also 249 
form complexes with some extracellular bacterial enzymes (Stern et al., 1996), thus reducing 250 
their effects. In most cases, the effects are dose dependent.   251 
An area that has received a lot of attention is the effect of seaweeds and particularly some 252 
of their metabolites, on the quorum sensing mechanism, by which bacterial cells communicate 253 
between each other. This process, which depends on the population density, involves the 254 
production of certain substances, such as peptides, or lactones, which are then released into 255 
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the extracellular environment. When the concentration of these substances increases beyond a 256 
certain level they are then detected by specific receptors, located in the bacterial cell 257 
membranes, or cytoplasms. This in turn regulates the expression of certain genes. Many Gram 258 
positive and negative bacteria use this process to collectively regulate many processes, such 259 
as bioluminescence, formation of biofilms and the production of various virulence factors 260 
(Manefield et al. 2001; Rutherford and Bussler 2012). Active substances released from 261 
seaweeds, such as furanones, can disrupt this process, thus affecting the virulence of many 262 
pathogenic bacteria, as for example the virulence of many pathogenic Vibrio species (Defoirdt 263 
et al., 2006) (Figure 2). Because of these properties and particularly the effect on the biofilm 264 
formation, seaweed extracts have also been studied as antifouling agents in aquaculture (Jha 265 
et al., 2013). It is worth mentioning that an important advantage of such quorum sensing 266 
inhibitors, is that they do not induce strong selection pressure on the bacteria, as antibiotics do 267 
(Dobretsov et al., 2009).   268 
Numerous studies have focused on the study of the direct antibacterial (either bactericidal 269 
or bacteriostatic) properties of seaweed extracts against human bacterial pathogens, such as: 270 
Bacillus subtilis, Enterococcus faecalis, Escherichia coli, Clostridium spp., Klebsiella 271 
pneumoniae, Pseudomonas aeruginosa, Proteus spp., Salmonella typhimurium, Shigella 272 
sonnei, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes and 273 
Vibrio cholerae (Vairappan and Suzuki, 2000; Vairappan et al., 2001; Xu et al., 2003; 274 
Christobel et al., 2011; Vijayabaskar and Shiyamala 2011; Ganeshamurthy et al., 2012; 275 
Marudhupandi and Kumar 2013; Saritha et al., 2013). In most cases, only in vitro assays were 276 
used to establish the antibacterial activities, such as disk diffusion or tube dilution methods.  277 
Most of the bacterial species that can cause diseases in fish and shrimp are quite 278 
ubiquitous in the aquatic environment, as for example many members of the genus 279 
Aeromonas and the various pathogenic Vibrio species, such as V. anguillarum (also known as 280 
Listonella anguillarum), V. alginolyticus and V. harveyi (Genovese et al., 2012; Cavalo et al., 281 
2013). Some of these bacteria, such as some pathogenic Vibrio species, can affect both fish 282 
and shrimp and in many cases the manifestation and the progress of the associated diseases 283 
are affected by the presence of various stressful conditions. In comparison to human bacterial 284 
pathogens, fewer studies have been conducted to identify the antibacterial potential of 285 
seaweed metabolites against these pathogens. 286 
Comparisons between the different studies on the antibacterial properties of seaweeds 287 
against fish and shrimp are difficult, as different experimental protocols were used and 288 
particularly in relation to the extraction methods. However, it is worth noticing that in only 5 289 
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out of the 28 studies on fish and shrimp bacterial pathogens, water was used for the extraction 290 
(Table 1). Although none of the three groups of seaweeds appears to be significantly more 291 
effective, as different species belonging to all groups are effective against many bacterial 292 
pathogens, Asparagopsis spp. (red seaweed) and Sargassum spp. (brown seaweed) appear to 293 
exhibit a broader range of antibacterial properties (Table 3). Interestingly, most studies were 294 
conducted in Asia (mainly India), while considerably fewer in other parts of the world, which 295 
can be associated with the extensive use of seaweed in the human diet in this area.  296 
 297 
Fish bacterial pathogens 298 
 299 
Antibacterial activities of seaweed extracts have been found against many Gram positive and 300 
Gram negative fish pathogenic bacteria, as many in vitro screenings have indicated (Table 3): 301 
many pathogenic Vibrio species, Aeromonas hydrophila and A. salmonicida, Edwarsiella 302 
tarda, Renibacterium salmoninarum, Photobacterium damselae sbsp piscicida, Pseudomonas 303 
anguilliseptica, Streptococcus iniae and Yersinia ruckeri (Vairappan and Suzuki, 2000; 304 
Bansemir et al., 2004; 2006; Dubber and Harder 2008; Ganeshamurthy et al., 2012; Genovese 305 
et al., 2012; Rebecca et al., 2012; Singh et al., 2012; Cavallo et al., 2013; Maheswaran et al., 306 
2013; Mata et al., 2013; Radhika et al., 2014).  307 
Few of these studies investigated the potential of using seaweeds to control bacterial 308 
pathogens in the aquatic environment (Figure 2). Lu et al. (2008) demonstrated the 309 
antimicrobial properties of Ulva clathrata in a series of experiments. In one experiment in 310 
particular, they added V. anguillarum in tanks containing cultures of the seaweed (10 g fresh 311 
algae L-1). The seaweed significantly reduced the growth of the bacterium in the water. 312 
However, the study did not include any experiment with fish and thus the applicability of 313 
these findings was not assessed. Mata et al. (2013) examined both in vitro and in vivo the 314 
antibacterial effect of the aqueous extracts bromoform and dibromoacetic acid from the red 315 
seaweed Asparagopsis taxiformis against the fish pathogen Streptococcus iniae. In that study, 316 
the extracts were added into the water containing barramundi (Lates calcarifer) fingerlings 317 
already infected with Streptococcus iniae. The findings indicated that addition of 318 
approximately 28 μg L−1 bromoform and 5 μg L−1 dibromoacetic acid could delay the growth 319 
of the bacterium in the water, but did not affect significantly the mortalities caused by 320 
Streptococcus iniae. This study however examined the activity of the extracts after the 321 
infection, while the possible prophylactic effect prior to infection was not investigated. 322 
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Addition of higher concentration of the extracts was more effective against the pathogen, but 323 
also induced mortality in the fish.  324 
 325 
Shrimp bacterial pathogens 326 
 327 
Almost all studies related to the antibacterial effects of seaweed extracts against shrimp 328 
pathogenic bacteria have focused on the bacterial genus Vibrio spp., as this represents the 329 
main bacterial group that can induce significant mortalities in shrimp farming (Defoirdt et al., 330 
2006; Baleta et al., 2011; Selvin et al., 2011; Dashtiannasab et al., 2012; Manilal et al., 2012; 331 
Cavalo et al., 2013; Silva et al., 2013; Sivakumar et al., 2014; Thanigaivel et al., 2014). When 332 
in vivo studies were carried out, the extracts were delivered to the shrimp mainly through 333 
enriched Artemia, or medicated dry feeds. In one study, the extracts were added into the water 334 
that contained infected shrimp (Thanigaivel et al., 2014). 335 
Traifalgar et al. (2009) examined and demonstrated the overall protective effect of 336 
fucoidan extracted from Undaria pinnatifida against Vibrio harveyi in post-larvae black tiger 337 
shrimp (Penaeus monodon). In that study, the shrimp that were fed with 500 - 2000 mg kg-1 338 
body weight for one month exhibited significantly lower mortality when infected artificially 339 
with the bacterial pathogen. Interestingly, the shrimp that were fed with the medicated feeds 340 
also exhibited improved growth performance. Selvin et al. (2011) confirmed the protective 341 
effect of Ulva fasciata extracts after feeding black tiger shrimp post-larvae with medicated 342 
feed for 2 weeks. Subsequently, they challenged the shrimp with four pathogens, namely 343 
Vibrio fischeri, V. harveyi, V. alginolyticus and Aeromonas spp. The group of shrimp fed with 344 
1 g kg-1 seaweed extract exhibited significantly lower mortality. Similarly, Manilal et al. 345 
(2012) examined the protective and therapeutic effect of ethyl acetate partitioned fraction of 346 
Asparagopsis spp. in black tiger shrimp post-larvae. For this, they fed the shrimp for 3 weeks 347 
and then challenged them with lethal doses of Vibrio harveyi, V. alginolyticus, V. 348 
parahaemolyticus and Photobacterium damselae. In this study, the authors examined the 349 
therapeutic effect as the shrimp were also fed with the medicated feed after the infection. 350 
Shrimp fed with 850 and 1150 mg kg−1 exhibited significantly increased survival rate. In all 351 
the above studies, the exact mode of action of the extracts was not determined.  352 
In a some studies, the authors attempted to explain the protective effect of the extracts 353 
only through their immunostimulatory properties. For example, Sirirustananun et al. (2011), 354 
studied the immunostimulatory effect of hot-water extract of Gracilaria tenuistipitata by 355 
feeding white shrimp (Litopenaeus vannamei) with 0.5, 1.0, and 2.0 g kg−1 dry diet for 14 356 
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days, before challenging them with V. alginolyticus and White Spot Syndrome Virus. The 357 
extracts induced a significant immunostimmulatory effect and increased survival rates. 358 
However, the study did not include any in vitro antibacterial assays, to indicate any possible 359 
direct antibacterial effect, which could also play an important role. 360 
Kanjana et al. (2011) studied both in vitro and in vivo the protective role of some solvent 361 
extracts of the red seaweed Gracilaria fisheri against Vibrio harveyi. After an initial screening 362 
using a disc-diffusion assay, the authors used only the ethanol extracts for further in vivo 363 
studies. For the in vivo study, the authors fed the shrimp with enriched Artemia salina instars 364 
II (either with 0.5 or 1.0 mg mL-1) for two weeks and then they artificially infected shrimp 365 
postlarvae with the bacterial pathogens. The results indicated both an antibacterial as well as 366 
an immunostimulatory effect (i.e. increased total haemocyte and granulocyte counts, 367 
increased phenoloxidase (PO) and superoxide dismutase (SOD) activities and increased super 368 
oxide anion production). Immanuel et al. (2004) also studied in vitro and in vivo the protective 369 
role of some seaweeds extracts against the shrimp pathogen Vibrio parahaemolyticus by 370 
feeding Penaeus indicus post-larvae with Artemia franciscana preadults enriched with 400 371 
mg L-1 of butanolic extracts from Ulva lactuca and Sargassum wightii. In this study, the 372 
authors maintained the shrimp in water containing the pathogen for 30 days, while fed them 373 
with the seaweed extract enriched Artemia. Interestingly, they found that the extract that 374 
exhibited the highest inhibition zone in the initial in vitro screening, also induced reduced 375 
bacterial load in the internal organs of the infected shrimp and increased the survival rate. 376 
Thanigaivel et al. (2014) conducted a study which has demonstrated the potential of using 377 
seaweed extracts as alternatives to antibiotics. The authors examined the antioxidant and 378 
antibacterial properties of an ethanol extract from the green seaweed Chaetomorpha 379 
antennina. Regarding the antibacterial properties, the authors first infected Penaeus monodon 380 
(mean weight 12 g) with V. parahaemolyticus and then treated the diseased shrimp by 381 
immersing them into water containing 250 mg L-1 of the seaweed extract for 12 – 48 h. This 382 
treatment resulted in 98% of survival of the treated shrimp. In addition, i.m. injection of 383 
25 μL of the extract per shrimp protected the animals when they were subsequently infected 384 
by the bacterial pathogen. This is the first report that shows the therapeutic effect of a short-385 
term administration of seaweed extracts. 386 
A recent study by Sivakumar et al. (2014) demonstrated possible mechanisms that could 387 
explain the antimicrobial properties of Ulva fasciata against the pathogen Vibrio harveyi. 388 
Thus, they demonstrated that solvent seaweed extracts reduced the phospholipase, proteolysis, 389 
lipolysis and thermonuclease activities of treated bacteria. The study included also an 390 
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immersion challenge trial, in which P. monodon postlarvae were maintained in water 391 
containing Vibrio harveyi for 30 days. Addition of 200 μg mL-1 of extracts into the water 392 
resulted in significantly reduced mortality. 393 
Defoirdt et al. (2006) examined the antibacterial effect of halogenated furanone extracted 394 
from the red seaweed Delisea pulchra against the shrimp bacterial pathogens Vibrio 395 
campbellii, V. harveyi, and V. parahaemolyticus. They reported that this natural product at the 396 
concentration of 20 mg L-1 could protect in vivo the brine shrimp Artemia franciscana against 397 
these bacterial pathogens, although the substance did not have any effect on the growth rate of 398 
the pathogens in the water. Higher concentrations were toxic to Artemia. The authors 399 
concluded that the protective effect was probably due to the disruption of the quorum sensing 400 
mechanism, as assessed by inhibition of bioluminescence, although a possible interaction 401 
between furanone and the shrimps was not excluded. Earlier, Manefield et al. (2000) had 402 
found that there is a link between bioluminescence and toxin production in V. harveyi and that 403 
the furanone that Defoirdt et al. (2006) also used could decrease the production of toxin by the 404 
bacterium. They also observed a protective effect in P. monodon, when they injected 405 
intramuscularly the animals with furanone-treated V. harveyi cultures. Rasch et al. (2004) 406 
examined the potential of using a synthetic halogenated furanone at significantly lower 407 
concentration (2.5 μg L-1) to minimize the mortality caused by Vibrio anguillarum in rainbow 408 
trout (Oncorhynchus mykiss). Although no natural seaweed extracts were used, the use of 409 
synthetic furanone decreased the mortality caused by the bacterial pathogen, probably through 410 
the disruption of the quorum sensing mechanism. As in the study by Defoirdt et al.(2006), no 411 
effect of the synthetic furanone were observed on the growth, the survival, the respiratory 412 
activity and the motility of the bacterium.  413 
 414 
Viral pathogens 415 
 416 
Currently no antiviral drugs are used in aquaculture and thus the study of any substance with 417 
antiviral properties that can be used against fish or shellfish viruses is of great importance. 418 
The strategies that are currently used in aquaculture to control viral diseases rely on the use of 419 
effective vaccines (mostly in fish farming) and the development of lines of animals resistant 420 
to certain diseases through selective breeding (Kibenge et al., 2012). In shrimp farming, oral 421 
administration of immunostimulants has been suggested as a particularly promising method 422 
against viral pathogens (Sivagnanavelmurugan et al., 2012), as vaccination is a rather 423 
experimental control method (Sudheer et al., 2012).  424 
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The antiviral properties of seaweed extracts against human viruses are well reported. 425 
Various water-soluble extracts from red, brown and green seaweeds and particularly sulfated 426 
polysaccharides, exhibit antiviral properties against many viruses, such as the herpes simplex 427 
viruses (Saha et al., 2012; Son et al., 2013), the Japanese encephalitis virus (flavivirus) (Chiu 428 
et al., 2012) and the influenza virus (Jiao et al., 2012). The antiviral activities against human 429 
viruses have been assessed mainly by in vitro studies, on cell lines, but also by in vivo studies, 430 
using experimental animals (e.g. mice). These studies have shown that the extracts can 431 
suppress the replication of the viruses, and delay the manifestation of the disease symptoms, 432 
increasing the survival rates of the infected animals. The active substances found in seaweed 433 
extracts include among others: sulfoglycolipids, carrageenans and fucoidans (Mohamed et al., 434 
2012). The mode of action depends on the substance but also on the virus. For instance, many 435 
sulfated polysaccharides may bind to the surface of the viruses (mainly enveloped viruses), or 436 
to virus receptors on the host cell surface, thus interfering with the attachment and the 437 
adsorption of the viruses to the host cells (Wang et al., 2012). Some carrageenans can also 438 
exhibit postbinding inhibitory effects, affecting the intracellular stages of the infection (Buck 439 
et al., 2006), and particularly the virus transcription and replication (Wang et al., 2012). 440 
Factors that may affect the antiviral properties of the sulfated polysaccharides include the 441 
sugar composition, the main chain length, the sulfation level and the sulfate pattern (Jiao et 442 
al., 2012). Phlorotannins from the brown seaweed Ecklonia cava were also found to exhibit 443 
inhibitory effect on HIV-1 reverse transcriptase and proteases (Ahn et al., 2004).  444 
Currently there is only one study that indicates a possible protective effect of seaweed 445 
extracts against fish viruses (Infectious Hemopoietic Necrosis Virus and Infectious Pancreatic 446 
Necrosis Virus), while there are many studies on White Spot Syndrome Virus of shrimp. In 447 
contrast to bacterial pathogens, both water and organic solvents were used for the extraction 448 
(Table 2). The seaweed species that exhibited the antiviral activity were: for WSSV: red 449 
seaweeds: Gracilaria tenuistipitata, brown seaweeds: Sargassum spp. and Cladosiphon 450 
okamuranus, green seaweeds: Acrosiphonia orientalis and for IHNV and IPNV the red 451 
seaweed Polysiphonia morrowii (Table 3). All studies discussed in the present review took 452 
place in Asia, probably because there is an increased interest to develop effective control 453 
strategies against WSSV, as no effective vaccines are yet available for the shrimp industry. 454 
 455 
Fish viral pathogens 456 
 457 
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Kim et al. (2011) used cell-based assay to assess the antiviral properties of the red alga 458 
Polysiphonia morrowii. They found that the 80% (v/v) methanolic extract had significant 459 
antiviral activity against two important fish viruses, the Infectious Hematopoietic Necrosis 460 
Virus (IHNV - family Rhabdoviridae) and the Infectious Pancreatic Necrosis Virus (IPNV - 461 
family Birnaviridae). Although, the study was in vitro and the authors did not provide any 462 
evidence on the mechanism of action of these extracts on the viruses, the results indicate the 463 
potential of using seaweed extracts against these viruses.  464 
 465 
Shrimp viral pathogens 466 
 467 
The White Spot Syndrome Virus (WSSV - family Nimaviridae) is the major pathogen 468 
affecting the shrimp production worldwide. WSSV can induce up to 100 % mortality within a 469 
few days, particularly at larval and juvenile stages. Various authors studied therefore the 470 
antiviral properties of the seaweed extracts in particular against the WSSV by administrated 471 
the extracts to shrimp either via enriched Artemia nauplii (Immanuel et al., 2010; Immanuel et 472 
al., 2012; Sivagnanavelmurugan et al., 2012), or through medicated feeds (Chotigeat et al., 473 
2004; Manilal et al., 2009). Based on these studies, the effective concentration of extracts that 474 
can be used to enrich Artemia ranges from 400 – 750 mg L-1, while the shrimp should be fed 475 
for about 20 days prior I order to acquire protection against the virus. On the other hand, 476 
medicated feeds were efficient when the seaweed extracts were added at a concentration of 477 
250-500 mg kg-1 body weight. The active components were found to be polysaccharides, in 478 
particular fucoidans and sodium alginates (Takahashi et al., 1998; Chotigeat et al., 2004; 479 
Manilal et al., 2009; Immanuel et al., 2012; Sivagnanavelmurugan et al., 2012). Chotigeat et 480 
al., (2004) examined in particular the prophylactic and therapeutic effect of crude fucoidan 481 
extracted from Sargassum polycystum against WSSV. Black tiger shrimps of different sizes 482 
were fed with medicated feed 4 days prior to and ten days after an experimental infection. The 483 
results showed that crude fucoidan at the concentration of 400 mg kg-1 of body weight day-1 484 
increased significantly the survival rate, while at the same time increased the phagocytic 485 
activity of the shrimp haemocytes. Similar results were obtained in an earlier study by 486 
Takahashi et al. (1998) who fed kuruma shrimp (Penaeus japonicus) with fucoidan extracted 487 
from the brown seaweed Cladosiphon okamuranus, at the concentration of 100 mg kg-1 of 488 
body weight day-1. 489 
In another study by Balasubramanian et al. (2006), the extracts, after their extraction by 490 
either water or organic solvents, were first mixed with suspensions of WSSV in order to de-491 
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activate the virus. Subsequently, the treated viral preparations were injected intramuscularly 492 
into marine shrimp (Penaeus indicus) and freshwater crab (Paratelphusa hydrodomous). 493 
Aqueous extracts of Sargassum weightii at a concentration of 3 mg per animal resulted in 494 
significantly less mortality in the infected animals.  495 
In all the above studies on WSSV, the mechanisms explaining the antiviral action of these 496 
seaweed extracts were not determined. However, apart from the immunostimulatory effects, a 497 
direct antiviral effect of the extracts similar to that observed in other viruses, cannot be 498 
excluded as a study by Rudtanatip et al. (2014) indicates. These authors reported that sulfated 499 
galactans isolated from the red seaweed Gracilaria fisheri attached to certain sites on the viral 500 
envelope and hence inhibited the attachment of the viruses to the host cells.  501 
 502 
Parasitic pathogens 503 
 504 
The antiparasitic properties of many seaweed extracts have been studied on a wide range of 505 
human parasites, such as protozoa, (e.g. Plasmodium spp. and Trichomonas spp.) (Moo-Puc et 506 
al., 2008; Vonthron-Sénécheau et al., 2011), helminthes (e.g. Ascaris spp.) (Higa and 507 
Kuniyosh, 2000) and insects (e.g. mosquito larvae) (Bianco et al., 2013). The mechanism of 508 
action varies according to the extracts and the parasites. Thus, the extracts can either interfere 509 
with the binding of the parasites to the target host cells and the subsequent invasion (Patel 510 
2012), or have a direct toxic effect on the parasites. For example, Moo-Puc et al. (2008) 511 
demonstrated the direct antiprotozoan activity of organic extracts derived from many seaweed 512 
species against Trichomonas vaginalis trophozoites, while Bianco et al. (2013) reported 513 
significant larvicidal activity of the red seaweed Laurencia dendroidea organic extracts 514 
against the larval stages of the mosquito Aedes aegypti. Despite the many studies on human 515 
parasites, the information on the antiparasitic properties of seaweeds against fish parasites is 516 
limited, while there are no published studies on shrimp parasites. 517 
Hutson et al. (2012) examined the effect of aqueous extracts from two seaweeds Ulva 518 
spp. and Asparagopsis taxiformis on the parasitism of barramundi (Lates calcarifer) by the 519 
monogenean ectoparasite Neobenedenia spp. The extracts, at the concentration of 1/100 v/v, 520 
mainly affected the initial stages of the cycle of the parasites. In particular, they inhibited the 521 
embryonic development, delayed the time of first and last hatching and reduced the hatching 522 
success rate of the parasite. The A. taxiformis extracts appeared substantially more effective. 523 
Both extracts however had no significant effect on the survival of the attached adult parasites, 524 
or the infection success of oncomiracidia. The authors suggested that these extracts could be 525 
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particularly effective in either closed or integrated farming systems, if these seaweed species 526 
are co-cultivated along with the fish. There was however no assessment of the applicability of 527 
this method under farming conditions. 528 
Ghany and Alla (2008) reported that when Nile tilapias (Oreochromis niloticus) 529 
experimentally infected with the protozoan fish endoparasite Ichthyophonus hoferi exhibited 530 
reduced mortality when fed post-infection with extracts from the seaweed Fucus vesiculosus 531 
(2 g Kg-1 body weight) for three months. It should be noted though that the study did not 532 
provide adequate information on the characteristics of the extracts, or how they were 533 
produced. 534 
 535 
Conclusions and future priorities 536 
 537 
Aquaculture is a growing industry and infectious diseases constitute one of the main 538 
limiting factors, affecting the production volume and cost. Assessment of the exact effects of 539 
the microbial diseases on the aquaculture production is very difficult, as there are direct and 540 
indirect effects. Stressful conditions can also compromise the immune system of fish and 541 
shellfish and subsequently reduce their response to any infectious agent (Huntingford et al., 542 
2006). 543 
Seaweeds represent a group of aquatic organisms which is an important part of the marine 544 
food chain, as well as the human diet. In addition to their nutritional value, they also exhibit 545 
antimicrobial, immunostimulatory and antioxidant properties. In the last 20 years, there is an 546 
increasing interest in using various seaweed extracts as prophylactic and therapeutic agents in 547 
aquaculture. 548 
Although there are fewer published studies on fish and shrimp pathogens compared to 549 
human and husbandry animal pathogens, the findings indicate that seaweeds can play an 550 
important role in the upcoming aquaculture sustainable practices.  551 
There are few published studies, which included both in vivo and in vitro assessment of 552 
the direct antimicrobial properties of seaweeds. Regarding the fish pathogens, almost all 553 
published information comes from in vitro screenings, where extracts of different seaweed 554 
species were tested against many bacterial pathogens, while there is only one published study 555 
on fish viruses (IHNV and IPNV) and two on fish parasites (I. hoferi and Neobendenia spp.). 556 
Interestingly, there are no published studies on salmons and carps, which are extensively 557 
farmed. The studies on shrimp have focused on the antimicrobial effects of seaweed extracts 558 
mainly against many Vibrio species and WSSV. Although all the studies indicate the overall 559 
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positive effect of the extracts, they do not elucidate the exact mechanism of action and 560 
particularly within the animal tissues (Figure 1). Furthermore, although it is known that many 561 
seaweed extracts also exhibit immunostimulatory properties, which can contribute to the 562 
protective effect, in most studies these effects were never examined in parallel to the 563 
antimicrobial effects.  564 
In general terms, all three groups of seaweeds (red, green and brown) exhibit 565 
antimicrobial properties, but the genera that appear to exhibit a broader range of activity are 566 
Asparagopsis spp (red). and Sargassum spp. (brown).  It should be noted though, that 567 
comparison between species is difficult, as there are many factors that can affect the 568 
antimicrobial properties, and the same seaweed species may exhibit different properties 569 
depending on the season, or the geographical area. 570 
The extraction method is also an important factor that can affect the efficacy of the 571 
produced extracts. In 27 out of 39 of the studies that are presented in this review, organic 572 
solvents were used for the extraction rather than water.  573 
The modes of delivery of the active seaweed substances can either be through the water 574 
(released directly from the seaweeds, or added into it after their extraction), or through 575 
medicated feed (again after their extraction), as outlined in Figure 2. In the first case, mainly 576 
water-soluble substances of seaweeds can be released or added into the aquatic environment 577 
of the farmed fish and shrimp. These substances appear to affect the quorum sensing 578 
mechanism in bacteria with limited effects on the bacterial growth. When the extracts are 579 
added into the feeds (live or dry), they can act directly against the pathogens or by stimulating 580 
the immune system. In addition, there are no complete pharmacodynamic and 581 
pharmacokinetic studies, which can demonstrate the exact mode of action of any seaweed 582 
extract. This important issue should be included in future studies.  583 
An important point that none of the published studies presented in our review has 584 
examined is the applicability of using any of these extracts on a commercial scale. The main 585 
issues related to this is the extraction cost and how the extracts can be delivered to fish or 586 
shrimp under the intensive farming conditions.  587 
The production cost of seaweeds varies according to the country and it can be between € 588 
160 and € 330 T-1 dry, in Asia and Europe respectively, but new seaweed culture techniques 589 
are expected to reduce this cost (Bruton et al. 2009). For the extraction of the active 590 
substances, there are a few methods that are available on a commercial scale and at the 591 
moment the cost of these methods is relatively high (Takahashi et al., 1998; Ibañez et al., 592 
2012). The yield of the active substances extracted from seaweed is between less than 1 % up 593 
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to 40 % of the dry algal mass, depending on various factors, such the metabolite, seaweed 594 
species and season (Pereira and Costa-Lotufo, 2012). Possible solutions to the high 595 
production cost can be the production of synthetic seaweed active compounds, as some of 596 
them exhibit properties similar to the natural substance (Rasch et al. 2004; Defoirdt el., 2006), 597 
or the incorporation of the responsible seaweed genes into microorganism as Pereira et al., 598 
(2012) suggested. However, some of these techniques have many complex steps and can be 599 
applied only when the antimicrobial effect of the natural analogs is well demonstrated. 600 
As discussed before, one mode of action is through the inhibition of the quorum sensing 601 
mechanism of the bacterial pathogens that exist in the water column, prior to infection. The 602 
active substances need to be constantly added into the water for long periods, as Rasch et al. 603 
(2004) did during their experimental challenges. Mata et al. (2013) examining the therapeutic 604 
effect of seaweed extracts also added the extracts to the water containing infected fish for a 605 
long period. In practice, this method can only be applied on land facilities, when fish are 606 
reared in small tanks and the water exchange rate is low (e.g. in hatcheries). In addition, the 607 
administration of therapeutics extracted from seaweed must be monitored continuously, as 608 
sudden increases of the concentration of the antimicrobial substance can be lethal (Rasch et al. 609 
2004; Mata et al. 2013) and exposure periods must be as short as possible (Thanigaivel et al., 610 
2014). More studies on short-term exposures are therefore required to confirm the efficacy of 611 
such treatments, particularly against parasitic pathogens.  612 
The safest delivery method reported is through medicated feed, as the dose of the extract 613 
per animal treated can be calculated more accurately. This method applies to all farming 614 
systems and can decrease the bacterial load in the tissues (Immanuel et al. 2004). Thus, this 615 
method of delivery will probably be the most effective and applicable one. Nevertheless more 616 
studies investigating the effect seaweed extracts on pathogens are necessary to support this 617 
hypothesis. 618 
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List of figures 932 
Figure 1. A general scheme used in the assessment of antimicrobial activity of seaweed 933 
extracts or metabolites. The initial in vitro screening indicates the best candidates for the in 934 
vivo studies. This stage can include many assays, depending on the bioactive component and 935 
its potential application. The in vivo studies are designed in such a way so that the important 936 
information is collected by using the minimum number of animals. Based on all available 937 
information, the best method of administration of the tested extract is then proposed. 938 
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Figure 2. Modes of administration of the seaweed extracts in fish and shrimp farming. 940 
 941 
31 
 
 
 
Table 1 Assessment of the antimicrobial properties of seaweed extracts against fish pathogens. 
 
  
Seaweed genus/species Extraction 
method 
Fish species In vitro assays In vivo assays Pathogen Results 
Ba
ct
er
ia
l 
 
Asparagopsis armataa (red) Organic 
solvents 
− Agar diffusion 
assay 
− Vibrio anguillarum  
Pseudomonas anguilliseptica 
Aeromonas salmonicida 
Aeromonas hydrophila 
Yersinia ruckeri 
In vitro 
antibacterial 
activity 
Laurencia chondrioidesb (red) Organic 
solvents 
− Agar diffusion 
assay 
− Vibrio anguillarum  
Pseudomonas anguilliseptica 
Aeromonas salmonicida 
Aeromonas hydrophila 
Yersinia ruckeri 
Photobacterium damselae 
sbsp piscicida 
In vitro 
antibacterial 
activity 
Mastocarpus stellatusc (red) 
Ceramium rubrumc (red) 
Laminaria digitatac (brown) 
Organic 
solvents 
− Bacterial 
growth 
inhibition 
assay 
− Aeromonas salmonicida  
Vibrio anguillarum   
Photobacterium damselae 
subsp. damselae   
Vibrio alginolyticus   
Yersinia ruckeri 
In vitro 
antibacterial 
activity 
Halimeda micronesiad (green) Organic 
solvents 
− Agar well 
diffusion assay 
− Aeromonas hydrophila 
Vibrio alginoticus 
V. parahaemolyticus 
Edwarsiella tarda 
In vitro 
antibacterial 
activity 
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Asparagopsis taxiformise (red) Organic 
solvents 
− Agar diffusion 
assay 
− Aeromonas salmonicida  
Photobacterium damselae 
subsp damselae 
Photobacterium damselae 
subsp piscicida  
Vibrio alginolyticus  
Vibrio harveyi  
Vibrio parahaemolyticus  
Vibrio vulnificus  
In vitro 
antibacterial 
activity 
Ulva spp.f (green) Organic 
solvents 
− Agar well 
diffusion assay 
− Aeromonas hydrophila 
Edwarsiella tarda 
In vitro 
antibacterial 
activity 
Padina gymnosporag (brown) 
Padina tetrastomaticag (brown) 
Sargassum wightiig (brown) 
Turbinaria ornatag (brown) 
 
Organic 
solvents 
− Disk diffusion 
assay 
Minimum 
inhibitory 
concentrations 
− Edwardsiella tarda 
Vibrio alginolyticus  
Aeromonas hydrophila 
Renibacterium 
salmoninarum 
In vitro 
antibacterial 
activity 
Gracilaria durah (red) 
Gracilaria gracilish (red) 
Gracilariopsis longissimah (red) 
Chaetomorpha linumh (green) 
Cladophora rupestrish (green) 
Ulva proliferah (green) 
Organic 
solvents 
− Disk diffusion 
assay 
− Vibrio ordalii 
Vibrio salmonicida 
Vibrio alginolyticus 
Vibrio vulnificus 
In vitro 
antibacterial 
activity 
33 
 
 
 
Gracilaria corticatai (red) 
Caulerpa racemosai (green)  
Caulerpa sertularioidesi (green)  
Chaetomorpha antenninai 
(green)   
Padina gymnosporai (brown) 
Sargassum wightiii (green)  
Organic 
solvents 
− Agar well 
diffusion assay 
− Vibrio parahaemolyticus  
Aeromonas hydrophila 
In vitro 
antibacterial 
activity 
Hypnea musciformisj (red) 
Gracilaria corticataj (red) 
Ulva fasciataj (green) 
Codium tomentosumj (green) 
Sargassum wightiij (brown) 
Dictyota dichotomaj (brown) 
Padina tetrastromaticaj (brown) 
Water _ Disk diffusion 
assay 
_ Vibrio alginolyticus 
Vibrio fischeri 
Vibrio harveyi 
In vitro 
antibacterial 
activity 
Ulva clathratak (green) Water _ Addition of 
bacterial 
suspension in 
seaweed 
cultures 
_ Vibrio anguillarum Inhibition of 
bacterial growth 
in the water 
Ulva reticulatal (green) Organic 
solvents 
_ Minimum 
inhibitory 
concentrations 
Enumeration 
of bacteria on 
the surface of 
seaweed 
_ Aeromonas hydrophila  
Vibrio alginolyticus 
Vibrio parahaemolyticus 
In vitro 
antibacterial 
activity 
Decrease in 
number of 
bacterial colonies 
Padina tetrastomaticam (brown) 
Stoechospermum marginatumm 
(brown) 
Ulva fasciatam (green) 
 
Organic 
solvents 
_ Agar well 
diffusion 
method 
_ Aeromonas hydrophila  
 
In vitro 
antibacterial 
activity 
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Asparagopsis taxiformisn (red) Water  Lates 
calcarifer  
Solid media 
antagonism 
assay 
Broth dilution 
assay 
Immersion 
challenge followed 
by administration 
of the extract 
through the water 
Streptococcus iniae  Delay of the 
growth of the 
bacterium in the 
water  
Not significant 
reduction in the 
mortality rate   
V
ir
al
 
Polysiphonia morrowiio (red) 
  
Organic 
solvents 
  
− 
  
Cytotoxicity 
assay 
Cytopathic 
effect 
reduction assay 
Plaque 
reduction assay 
Cytotoxicity 
assay. 
− 
  
Infectious Hematopoietic 
Necrosis Virus 
Infectious Pancreatic  
Necrosis Virus 
  
In vitro antiviral 
activity 
  
Pa
ra
sit
ic
 
Fucus vesiculosusp (brown) − Oreochromis 
niloticus  
− Feeding trial using 
naturally infected 
fish 
Ichthyophonus hoferi  Reduced mortality 
Ulva spp.q (green)          
Asparagopsis taxiformisq (red) 
Water Lates 
calcarifer 
Immersion 
treatment of 
various 
developmental 
stages of the 
parasites. 
Immersion 
treatment of 
infected fish 
Neobenedenia spp.  Inhibition of the 
embryonic 
development, 
increase in the 
time of first and 
last hatch and 
reduced hatching 
success of the 
parasite 
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a Bansemir et al. (2006); b Bansemir et al. (2004); c Dubber and Harder (2008); d Ganeshamurthy et al. (2012); e Genovese et al. (2012); f Rebecca et al. (2012); 
g Singh et al. (2012); h Cavallo et al. (2013); i Maheswaran et al. (2013),  j Christobel et al. (2011) k Lu et al. (2008); l Vairappan and Suzuki (2000); m Radhika et 
al. (2014), n Mata et al. (2013); o Kim et al. (2011); p El Ghany and Alla (2008); q Hutson et al. (2013) 
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Table 2 Assessment of the antimicrobial properties of seaweed extracts against shrimp pathogens. 
 
  
Seaweed genus/species Extraction 
method 
Shrimp 
species 
In vitro assays In vivo assays Pathogen Results 
Ba
ct
er
ia
l 
Undaria pinnatifidaa (brown) Organic 
solvents 
Penaeus 
monodon  
− Feeding trial and 
immersion challenge 
Vibrio harveyi Reduced mortality 
Ulva fasciatab (green) 
 
Organic 
solvents 
Penaeus 
monodon  
− Feeding trial and 
injection challenge 
Vibrio alginolyticus 
V. harveyi  
Aeromonas spp. 
Reduced mortality 
Asparagopsis spp.c (red) Organic 
solvents 
Penaeus 
monodon  
− Feeding trial and 
injection challenge 
Vibrio harveyi 
Vibrio alginolyticus 
Vibrio parahaemolyticus 
Photobacterium damsela 
Reduced mortality 
Gracilaria tenuistipitatad (red) Water Litopenaeus 
vannamei 
− Feeding trial and 
injection challenge 
Vibrio alginolyticus Reduced mortality 
Gracilaria fisherie (red) Organic 
solvents 
Penaeus 
monodon  
Disk diffusion 
assay 
Minimum 
inhibitory 
concentrations  
Safety test for the 
seaweed ethanol 
extract 
Enrichment of 
Artemia salina 
Immersion 
challenge of shrimp 
postlarvae and 
juveniles 
Vibrio harveyi In vitro 
antibacterial effect 
Reduced mortality 
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Ulva lactucaf (green) 
Sargassum wightiif (brown) 
Organic 
solvents 
Penaeus 
indicus  
Disk diffusion 
assay 
Enrichment of A. 
salina 
Immersion 
challenge of shrimp 
juveniles 
Vibrio parahaemolyticus In vitro 
antibacterial effect  
Reduced bacterial 
load in the internal 
organs 
Reduced mortality 
Delisea pulchrag (red) 
Synthetic furanoneg 
Organic 
solvents 
Artemia 
franciscana  
Growth 
inhibition of 
furanone in 
liquid growth 
medium and 
water (plate 
counts) 
Disruption of 
AI-2 quorum 
sensing by 
synthetic 
furanone 
Addition of the 
extract into the 
water and challenge 
tests 
Vibrio harveyi 
Vibrio campbellii 
Vibrio parahaemolyticus 
Disruption of the 
quorum sensing 
mechanism 
Sargassum polycystumh (brown) 
  
Water 
  
Penaeus 
monodon  
  
Agar diffusion 
assay 
Minimum 
inhibitory 
concentrations  
Feeding trial and 
incubation challenge 
  
Vibrio harveyi 
  
Reduced mortality 
  
Ulva fasciatai (green) Organic 
solvents 
Penaeus 
monodon  
 
Agar well 
diffusion assay 
Minimum 
inhibitory 
concentrations 
Effect on 
virulence factors 
Immersion 
challenge 
Vibrio harveyi 
 
In vitro 
antibacterial effect 
Reduced activity 
of many virulence 
factors 
Reduced mortality 
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Delisea pulchraj (red) 
 
Organic 
solvents 
Penaeus 
monodon  
Inhibition of 
luminescence 
T1 toxin 
production 
 
Toxicity of 
supernatant extracts 
from furanone-
treated V. 
harveyi cultures 
assess by  i.m. 
injection 
Vibrio harveyi Inhibition of 
luminescence and 
T1 toxin 
production 
Reduced mortality 
 
Chaetomorpha antenninak 
(green) 
Organic 
solvents 
Penaeus 
monodon 
Well diffusion 
method 
Immersion treatment 
after i.m. and 
immersion challenge 
I.m injection of 
extract followed by 
infection 
Vibrio parahaemolyticus, In vitro 
antibacterial effect 
Therapeutic effect 
after challenge 
Improved 
histological 
picture after 
treatment with the 
extracts 
Protective effect of 
the i.m. injection 
of the extract 
Padina gymnosporal (brown) Organic 
solvents 
− Disk diffusion 
assay 
− Vibrio parahaemolyticus, 
Vibrio brasiliensis,  
Vibrio xuii, 
Vibrio navarrensis 
In vitro 
antibacterial effect 
Sargassum oligocystum m 
(brown) 
Organic 
solvents 
− Disk diffusion 
method 
− Vibrio alginolyticus,  
Vibrio parahaemolyticus  
Vibrio harveyi 
In vitro 
antibacterial effect 
Sargassum latifoliumn (brown) Organic 
solvents 
− Disk diffusion 
method 
− Vibrio alginolyticus,  
Vibrio parahaemolyticus  
Vibrio harveyi 
In vitro 
antibacterial 
activity 
39 
 
 
 
V
ir
al
 
Sargassum wightiio (brown) Organic 
solvents 
 − Enrichment of 
Artemia nauplii with 
fucoidan 
Immersion 
challenge 
White Spot Syndrome Virus Reduced mortality 
Sargassum wightiip (brown) 
Sargassum duplicatump (brown) 
  
Water  Penaeus 
monodon  
− Enrichment of A. 
salina 
Immersion 
challenge of shrimp 
postlarvae 
White Spot Syndrome Virus Reduced mortality 
Sargassum wightiiq (brown) Organic 
solvents 
Penaeus 
monodon  
− Enrichment of 
Artemia  
franciscana nauplii 
Immersion 
challenge 
Viral load using 
nested PCR 
White Spot Syndrome Virus Reduced mortality 
Sargassum polycystumh (brown) Water Penaeus 
monodon  
− Feeding trial and 
immersion challenge 
White Spot Syndrome Virus Reduced mortality 
Acrosiphonia orientalisr (green) Organic 
solvents 
Penaeus 
monodon  
− 
 
Feeding trial and 
immersion challenge 
White Spot Syndrome Virus Reduced mortality 
Cladosiphon okamuranuss 
(brown) 
− Penaeus 
japonicus 
− Feeding trial and 
immersion challenge 
White Spot Syndrome Virus Reduced mortality 
Sargassum wightiit (brown) Water Penaeus 
indicus  
Paratelphusa 
hydrodomous 
− Determination of 
viral inactivation 
using i.m. injection 
of shrimp 
White Spot Syndrome Virus Reduced mortality 
Gracilaria tenuistipitatad (red) Water Litopenaeus 
vannamei 
− Feeding trial and 
injection challenge 
White Spot Syndrome Virus Reduced mortality 
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a Traifalgar et al. (2009); b Selvin et al. (2011); c Manilal et al. (2012); d Sirirustananun et al. (2011); e Kanjana et al. (2011); f Immanuel et al. (2004); g Defoirdt et 
al. (2006); h Chotigeat et al. (2004); i Sivakumar et al. (2014); j Manefield et al. (2000), k Thanigaivel et al. (2014), l Silva et al. (2013), m Baleta et al. (2011), n 
Dashtiannasab et al. (2012), o Sivagnanavelmurugan et al.  (2012); p Immanuel et al. (2010); q Immanuel et al. (2012); r Manilal et al. (2009); s Takahashi et al. 
(1998); t Balasubramanian et al. (2006). 
 
  
41 
 
 
 
Table 3. Seaweed species tested against fish and shrimp pathogens. The table summarizes the findings presented in Tables 1 and 2 of this review. 
 
Seaweed genus/pecies Geographical area Pathogen 
Red seaweeds   
Asparagopsis armata Atlantic, France Vang, Pang, Asal, Ahyd, Yruc 
Asparagopsis taxiformis Italy Valg, Vpar, Vhar, Vvul, Asal, Pdad, Pdap,  
Asparagopsis taxiformis Australia Sini, Neo 
Ceramium rubrum North Sea Asal, Valg, Yruc 
Delisea pulchra India Vhar, Vcam, Vpar 
Delisea pulchra Australia Vhar 
Gracilaria corticata India Vpar, Ahyd, Valg, Vhar, Vfis 
Gracilaria dura Italy Vord, Valg 
Gracilaria fisheri Thailand Vhar 
Gracilaria gracilis Italy Vsal 
Gracilaria tenuistipitata Taiwan Valg, WSSV 
Gracilariopsis longissima Southern Italy Valg, Vvul 
Hypnea musciformis India Vhar, Vfis 
Laurencia chondrioides Gran Canaria Vang, Pang, Asal, Ahyd, Yruc, Pdapi 
Mastocarpus stellatus North Sea Asal, Vang 
Polysiphonia morrowii South Korea IHNV, IPNV 
   
Green seaweeds     
Acrosiphonia orientalis India WSSV 
Caulerpa racemosa India Vpar, Ahyd 
Caulerpa sertulrioides India Vpar, Ahyd 
Chaetomorpha antennina India Vpar, Ahyd 
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Chaetomorpha linum Southern Italy Vvul, Vord 
Chladophora rupestris Southern Italy Vvul, Vsal, Vord 
Codium tomentosum India Valg, Vhar, Vfis 
Halimeda micronesia India Valg, Vpar, Ahyd, Etar 
Ulva clathrata China Vang 
Ulva fasciata India Valg, Vhar, Vfis, Aero 
Ulva prolifera Southern Italy Vord 
Ulva lactuca India Vpara 
Ulva reticulata Malaysia Valg, Vpar, Ahyd 
Ulva spp. Australia  Neo 
   
Brown seaweeds     
Cladosiphon okamuranus Japan* WSSV 
Dictyota dichotoma India Valg 
Fucus vesiculosus Egypt* Icth 
Laminaria digitata North Sea Vang, Pdada, Yruc 
Padina gymnospora India  Vpar, Ahyd, Valg,  
Padina gymnospora Brazil Vpar, Vbra, Vxui, Vnav 
Padina tetrastomatica India  Valg, Vhar, Etar, Ahyd 
Sargassum duplicatum India WSSV 
Sargassum latifolium Persian Gulf Vpar, Valg, Vhar 
Sargassum oligocystum Philippines Vpar, Valg, Vhar 
Sargassum polycystum Thailand Vhar, WSSV 
Sargassum wightii India  Vpar, Ahyd, Valg, Vhar, Vfis, Rsal, WSSV 
Stoechospermum marginatum India Ahyd 
Undaria pinnatifida Japan Vhar 
Turbinaria ornata India Rsal 
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Aero=Aeromonas spp., Ahyd=Aeromonas hydrophila, Asal=Aeromonas salmonicida, Etar=Edwardsiella 
tarda, Icth=Ichthyophonus hoferi, IHNV=Infectious Hemopoietic Necrosis Virus, IPNV=Infectious 
Pancreatic Necrosis Virus, Neo=Neobenedenia spp., Pang=Pseudomonas anguilliseptica, 
Pdad=Photobacterium damselae sbsp damselae, Pdap=Photobacterium damselae sbsp piscicida, 
Rsal=Renibacterium salmoninarum, Sini=Streptococcus iniae, Valg=Vibrio alginolyticus, Vang=Vibrio 
anguillarum, Vbra=Vibrio brasiliensis, Vcam=Vibrio campelii, Vfis=Vibrio fischeri, Vhar=Vibrio harveyi,  
Vord=Vibrio ordalii, Vpar=Vibrio parahaemolyticus,  Vsal=Vibrio salmonicida, Vvul=Vibrio vulnificus, 
Vxui=Vibrio xuii, WSSV=White Spot Syndrome Virus, Yruc=Yersinia ruckeri, *Area where the study took 
place.  
The relevant references are cited in Tables 1 and 2. 
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